Personalized Computerized Inhibitory Control Training for OCD
1 other identifier
interventional
11
1 country
1
Brief Summary
This study will evaluate the effects of a computerized training program coupled with cognitive behavioral therapy (CBT) for OCD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2015
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2015
CompletedFirst Submitted
Initial submission to the registry
February 27, 2015
CompletedFirst Posted
Study publicly available on registry
March 4, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2018
CompletedJanuary 29, 2018
January 1, 2018
2.8 years
February 27, 2015
January 25, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Obsessive-compulsive symptoms measured after 3 weeks of treatment
measured by Yale Brown Obsessive Compulsive Scale (YBOCS)
3 weeks
Study Arms (1)
CBT + Personalized Computer Program
EXPERIMENTALCognitive Behavioral Therapy (CBT), consisting of Exposure and Ritual Prevention Therapy and training with a personalized computerized inhibitory training program
Interventions
Training with a personalized computerized inhibitory training program
Cognitive Behavioral Therapy (CBT), consisting of Exposure and Ritual Prevention Therapy
Eligibility Criteria
You may qualify if:
- Principal diagnosis of OCD (assessed by SCID).
- Clinically significant OCD symptoms (Y-BOCS score of at least 16).
- Have a history of completing a trial of at least 1 EX/RP sessions.
- Have access to a computer or laptop.
You may not qualify if:
- Individuals with the following disorders will excluded: bipolar, psychosis, current major depressive disorder (assessed by SCID).
- Patients with head injury and loss of consciousness of more than five minutes or a neurological condition affecting the central nervous system.
- Patients taking a psychiatric medication will be asked to maintain a stable dose for 6 weeks prior to study entry.
- Vision or hearing loss (although individuals with vision corrected by glasses or contacts will not be excluded).
- Active suicidality warranting immediate clinical care.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
New York State Psychiactic Institute
New York, New York, 10032, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Helen B Simpson, M.D., PhD
New York State Psychiactic Institute, Anxiety Disorders Clinic
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 27, 2015
First Posted
March 4, 2015
Study Start
February 1, 2015
Primary Completion
December 1, 2017
Study Completion
January 1, 2018
Last Updated
January 29, 2018
Record last verified: 2018-01